Details of Disease

Disease Name

Disease Class

ED91: Sebaceous gland disorder

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISQ9VQM: Seborrhea

ICD-11

ICD-11: ED91.2

ICD-10

ICD-10: L73.8

Expand ICD-11

'ED91.2

Expand ICD-10

'L73.8

Disease Identifiers

MONDO ID

MONDO_0005339

MESH ID

D000505

UMLS CUI

C0162311

MedGen ID

56404

SNOMED CT ID

201144006

General Information of Disease (ID: DISQ9VQM)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
SMT-D002	DM1I93C	Approved	NA	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
MTC-896	DM7VG8L	Phase 2	NA	[2]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
M-110101	DM28YZD	Investigative	NA	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	Clinical pipeline report, company report or official report of Summit.
2	ClinicalTrials.gov (NCT02395549) A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris. U.S. National Institutes of Health.
3	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.